Condition 101 About Acute Myeloblastic Leukemia without Maturation

What are the alternative names for Acute Myeloblastic Leukemia without Maturation?

  • Acute myeloblastic leukemia type 1
  • Acute myeloblastic leukemia M1
  • AML M1

Latest Advances On Acute Myeloblastic Leukemia without Maturation

  • Condition: Intermediate-Risk Acute Myeloid Leukemia
  • Journal: Annals of hematology
  • Treatment Used: Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
  • Number of Patients: 127
  • Published —
This study tested the safety and efficacy of using allo-HSCT to treat patients with intermediate-risk acute myeloid leukemia.
  • Condition: Acute Monocytic Leukemia
  • Journal: Zhongguo shi yan xue ye xue za zhi
  • Treatment Used: Allogeneic Hematopoietic Stem Cell Transplantation
  • Number of Patients: 71
  • Published —
The study researched the outcomes of allogeneic hematopoietic stem cell transplantation for treating acute monocytic leukemia.

Clinical Trials For Acute Myeloblastic Leukemia without Maturation

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Other, Drug, Radiation, Procedure, Biological
  • Participants: 240
  • Start Date: June 1, 2021
A Randomized Phase II Study to Compare ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Behavioral
  • Participants: 20
  • Start Date: May 31, 2021
A Telehealth Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome